These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21299485)

  • 21. Too few, too weak: conflict of interest policies at Canadian medical schools.
    Shnier A; Lexchin J; Mintzes B; Jutel A; Holloway K
    PLoS One; 2013; 8(7):e68633. PubMed ID: 23861928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Industry support of medical education.
    Relman AS
    JAMA; 2008 Sep; 300(9):1071-3. PubMed ID: 18768419
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationships between drug company representatives and medical students: medical school policies and attitudes of student affairs deans and third-year medical students.
    Sierles F; Brodkey A; Cleary L; McCurdy FA; Mintz M; Frank J; Lynn DJ; Chao J; Morgenstern B; Shore W; Woodard J
    Acad Psychiatry; 2009; 33(6):478-83. PubMed ID: 19933893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).
    Bruyere O; Kanis JA; Ibar-Abadie ME; Alsayed N; Brandi ML; Burlet N; Cahall DL; Chines A; Devogelaer JP; Dere W; Goel N; Hughes N; Kaufman JM; Korte S; Mitlak BH; Niese D; Rizzoli R; Rovati LC; Reginster JY
    Osteoporos Int; 2010 May; 21(5):713-22. PubMed ID: 20238101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conflict-of-interest policies.
    Ratain MJ; Sheridan ME
    N Engl J Med; 2001 Mar; 344(13):1018. PubMed ID: 11280317
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantity and quality of conflict of interest policies at German medical schools: a cross-sectional study and survey.
    Grabitz P; Friedmann Z; Gepp S; Hess L; Specht L; Struck M; Tragert SK; Walther T; Klemperer D
    BMJ Open; 2020 Sep; 10(9):e039782. PubMed ID: 32998930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug reps off campus! Promoting professional purity by suppressing commercial speech.
    Stell LK
    J Law Med Ethics; 2009; 37(3):431-43, 395. PubMed ID: 19723254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conflict-of-interest policies.
    Topol EJ
    N Engl J Med; 2001 Mar; 344(13):1017; author reply 1018. PubMed ID: 11280315
    [No Abstract]   [Full Text] [Related]  

  • 29. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.
    Coleman DL; Kazdin AE; Miller LA; Morrow JS; Udelsman R
    Acad Med; 2006 Feb; 81(2):154-60. PubMed ID: 16436576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conflicts of interest in medical education: recommendations from the Pew task force on medical conflicts of interest.
    Korn D; Carlat D
    JAMA; 2013 Dec; 310(22):2397-8. PubMed ID: 24327035
    [No Abstract]   [Full Text] [Related]  

  • 31. Conflict-of-interest policies for investigators in clinical trials.
    Lo B; Wolf LE; Berkeley A
    N Engl J Med; 2000 Nov; 343(22):1616-20. PubMed ID: 11096170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Content and strength of conflict of interest policies at Scandinavian medical schools: a cross sectional study.
    Fabbri A; Mulinari S; Johansson M; Ghaur W; Khalil AM; Lundh A
    BMC Med Educ; 2022 Nov; 22(1):812. PubMed ID: 36435782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conflict of Interest Policies at French Medical Schools: Starting from the Bottom.
    Scheffer P; Guy-Coichard C; Outh-Gauer D; Calet-Froissart Z; Boursier M; Mintzes B; Borde JS
    PLoS One; 2017; 12(1):e0168258. PubMed ID: 28068362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary: Conflict of interest policies: an opportunity for the medical profession to take the lead.
    Lo B
    Acad Med; 2010 Jan; 85(1):9-11. PubMed ID: 20042812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical students' attitudes toward interactions with the pharmaceutical industry: a national survey in Japan.
    Saito S; Maeno T; Miyata Y; Maeno T
    BMC Med Educ; 2018 Dec; 18(1):286. PubMed ID: 30509273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gaps in adopting conflicts of interest policies among u.s. Medical schools.
    Lang L
    Gastroenterology; 2008 Apr; 134(4):905-6. PubMed ID: 18395066
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of academic scientists' responses to situations that pose a conflict of interest.
    Sax JK; Doran N
    Cancer Biol Ther; 2011 Jul; 12(1):4-8. PubMed ID: 21525792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confronting conflict: addressing institutional conflicts of interest in academic medical centers.
    Liang BA; Mackey T
    Am J Law Med; 2010; 36(1):136-87. PubMed ID: 20481404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for interactions with pharmaceutical companies.
    American Medical Association. Resident Physicians Section
    JAMA; 1993 Sep; 270(10):1250. PubMed ID: 11643149
    [No Abstract]   [Full Text] [Related]  

  • 40. Relations between health professionals and industry: conflicts of interest.
    Prescrire Int; 2000 Aug; 9(48):126. PubMed ID: 11067728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.